Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background Preclinical and clinical research suggest that the α1 receptor antagonist prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role of prazosin in treating Post-Traumatic Stress Disorder (PTSD) symptoms, while a recent trial suggested that pre-treatment blood pressure (BP) predicts therapeutic response for prazosin in PTSD patients. Whether pre-treatment BP may predict response to α1 blockers in alcohol-dependent (AD) patients is unknown. We previously reported a randomized controlled trial (RCT), where doxazosin, an α1 receptor antagonist with a more favorable pharmacokinetic profile than prazosin, reduced drinks per week (DPW) and heavy drinking days (HDD) in AD patients with a high family history density of alcoholism. In this study, we tested pre-treatment BP as another potentially valuable clinical moderator of doxazosin’s response on alcohol consumption. Methods This was a double-blind placebo-controlled RCT testing doxazosin up to 16 mg/day in AD treatment-seeking patients (N = 41). The hypothesized moderator effect of baseline standing systolic and diastolic BP on DPW and HDD was tested. Results With pre-treatment standing diastolic BP as a moderator, there were significant BP × medication interactions for both DPW [**p= 0.009, d = 0.80] and HDD [*p = 0.018, d = 1.11]. Post-hoc analyses indicated significant doxazosin effects in patients with higher standing BP in reducing both DPW and HDD. Conclusion These findings suggest that higher standing diastolic BP at baseline (pre-treatment) may represent a predictor of doxazosin’s response on alcohol consumption in AD patients. These results further elucidate the possible efficacy and mechanisms of action of α1 receptor antagonism in AD individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rhemtulla, M., Brosseau-Liard, P. É., & Savalei, V. (2012) · Psychological Methods · doi:10.1037/a0029315 · Cited by 2,816 · cited 2×
“…while diastolic BP> 80 mmHg reflects a pre-hypertensive or hypertensive status; 2) from a statistical standpoint, consistent with previous reports (Rhemtulla et al., 2012), categorical variables are less influenced by outliers and are preferred for a smaller sample size; and 3) from a…”
ResultA Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 4×
“may be a potentially effective pharmacological approach to AUD treatment (Koob, 2008; Trzaskowska et al., 1986; Walker et al., 2008).”
BackgroundInfluentialThe role of stress in addiction relapse
Sinha, R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0050-6 · Cited by 423
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Profile of Mood States: the factors and their physiological correlates.
POLLOCK, V., CHO, D. W., REKER, D., & VOLAVKA, J. (1979) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197910000-00004 · Cited by 143 · cited 2×
“Anxiety and stress were assessed using the Hamilton Anxiety Scale (HAMA) (Hamilton, 1959), the Anxiety-Tension Subscale of the Profile of Mood States (POMS-TA) (Pollock et al., 1979), and the Perceived Stress Scale (PSS) (Cohen et al.”
MethodWhat the alcohol doctor ordered from the neuroscientist
Heilig, M., & Leggio, L. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.07.023 · Cited by 25 · cited 1×
“Therefore, identifying personalized medicine approaches and biomarkers of medication response are crucial steps in medication development for AUD (Heilig and Leggio, 2016).”
BackgroundSelf-citation
Cited by
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
“However, further examination of clinical moderators revealed that doxazosin significantly reduced drinks per week and heavy-drinking days among individuals with higher family history of AUD and higher standing diastolic blood pressure [209].”
BackgroundNoradrenergic targets for the treatment of alcohol use disorder
Haass-Koffler, C. L., Swift, R. M., & Leggio, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4843-6 · Cited by 117
Self-citationVanderkam, P., Solinas, M., Ingrand, I., Doux, N., Ebrahimighavam, S., Jaafari, N., & Lafay‐Chebassier, C. (2021) · Addiction · doi:10.1111/add.15265 · Cited by 25
Noradrenergic Mechanisms and Circuitry of Hyperkatifeia in Alcohol Use Disorder
Varodayan, F. P., Erikson, C. M., Scroger, M. V., & Roberto, M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.009 · Cited by 12
Metadata
- Authors
- Haass-Koffler, C. L., Goodyear, K., Zywiak, W. H., Magill, M., Eltinge, S. E., Wallace, P. M., Long, V. M., Jayaram-Lindström, N., Swift, R. M., Kenna, G. A., & Leggio, L.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 177
- Pages
- 23-28
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2614277232
- Cited by
- 47
- References
- 6
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2017.03.016
- The paper
- Haass-Koffler, C. L., Goodyear, K., Zywiak, W. H., Magill, M., Eltinge, S. E., Wallace, P. M., Long, V. M., Jayaram-Lindström, N., Swift, R. M., Kenna, G. A., & Leggio, L. (2017). Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2017.03.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.